The Bio Report
Levine Media Group
EN1239 episodes
sciencelifebusinesshealthfitnessmedicine
The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.
Episodes (1239)
How One Company Is Reinventing Drug Development
The Bio Report
Mar 19, 201533:54pending
Why Patent Trolling Threatens Biopharma
The Bio Report
Mar 13, 201515:56pending
Shifting Venture Investment Raises Concerns
The Bio Report
Mar 5, 201517:11pending
Will Policy Triumph Over Politics in 21st Century Cures Act
The Bio Report
Feb 26, 201520:46pending
Democratizing the World of Healthcare Analytics
The Bio Report
Feb 19, 201518:46pending
Will Funding for Obama’s Precision Medicine Initiative Match Its Ambition
The Bio Report
Feb 12, 201516:35pending
Should Investors Temper Their Enthusiasm for CAR-T Therapies
The Bio Report
Feb 5, 201524:23pending
What to Do About the United States’ Declining Investment in R&D
The Bio Report
Jan 29, 201516:07pending
Why Big Pharma Hasn’t Been Able to Fix Its Revenue Gap with M&A
The Bio Report
Jan 22, 201517:26pending
Remembering Industry Pioneer Ron Cape
The Bio Report
Jan 15, 201527:09pending
Moving from Chronic Therapies to Cures
The Bio Report
Jan 8, 201522:07pending
What’s in Store for the Biotech Industry in 2015
The Bio Report
Dec 31, 201418:07pending
A Look at the Year That Was in Biotech
The Bio Report
Dec 24, 201415:15pending
Why Privacy Concerns May Limit Big Data’s Payoff
The Bio Report
Dec 18, 201413:40pending
Calculating the Cost of Drug Development and What it Means
The Bio Report
Dec 11, 201420:13pending
How New Funding Models Are Accelerating Drug Development
The Bio Report
Dec 4, 201418:12pending
Telemedicine Grows, but Reimbursement Remains an Obstacle
The Bio Report
Nov 28, 201422:27pending
The Power of IBM’s Watson Is Coming to an App Near You
The Bio Report
Nov 20, 201418:01pending
Brittany Maynard and the Debate over the Right to Die
The Bio Report
Nov 13, 201423:04pending
What’s Driving the Booming Market for Orphan Drugs
The Bio Report
Nov 6, 201418:28pending
Why Interoperability Is Much More than a Technology Problem
The Bio Report
Oct 30, 201426:24pending
The Lean Startup Takes Hold in the Life Sciences
The Bio Report
Oct 23, 201422:54pending
Enlisting Monoclonal Antibodies to Combat Bacterial Resistance
The Bio Report
Oct 16, 201421:16pending
The Forces Bringing Disruptive Change to Healthcare
The Bio Report
Oct 9, 201421:13pending
How One Foundation is Getting the Biggest Bang for Its R&D Bucks
The Bio Report
Oct 2, 201428:25pending
International Collaboration Seeks to Drive Breakthroughs in Progressive MS
The Bio Report
Sep 24, 201423:36pending
Will Increased FDA Regulation of Diagnostics Speed or Slow Development of Person...
The Bio Report
Sep 18, 201426:45pending
Using Human Biology to Improve R&D
The Bio Report
Sep 11, 201428:21pending
Reengineering Drug Discovery and Development
The Bio Report
Sep 4, 201421:02pending
The Year in Biotech So Far and What’s Ahead
The Bio Report
Aug 28, 201421:36pending
Epirus Sees Opportunities for Biosimilars Outside U.S.
The Bio Report
Aug 21, 201417:33pending
......